Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Two More Firms Recall Diabetes Drug
07/09/2020
Two more firms have recently joined several others and are recalling a prescription medication used to help control blood sugar levels in people with type 2 diabetes.
Two more firms have recently joined several others and are recalling a prescription medication used to help control blood sugar levels in people with type 2 diabetes.
Two more firms have recently...
07/09/2020
Pharmacy Learning Network

Advertisement

News
Menopause Medication Recalled
07/02/2020
The FDA has issued a Class III recall for a fixed-dose combination medication used to treat menopause symptoms and postmenopausal osteoporosis.
The FDA has issued a Class III recall for a fixed-dose combination medication used to treat menopause symptoms and postmenopausal osteoporosis.
The FDA has issued a Class III...
07/02/2020
Pharmacy Learning Network
News
Label Mistake Prompts Antipsychotic Recall
07/02/2020
Mislabeled bottles have prompted Alembic Pharmaceuticals Limited to recall a prescription antipsychotic medication used to treat patients with schizophrenia, bipolar disorder, depression, and Tourette syndrome.
Mislabeled bottles have prompted Alembic Pharmaceuticals Limited to recall a prescription antipsychotic medication used to treat patients with schizophrenia, bipolar disorder, depression, and Tourette syndrome.
Mislabeled bottles have prompted...
07/02/2020
Pharmacy Learning Network
News
Diabetes Drug Recall Grows
07/02/2020
Teva Pharmaceuticals USA is recalling diabetes tablets due to an analysis by the FDA that detected NDMA impurities above an acceptable level.
Teva Pharmaceuticals USA is recalling diabetes tablets due to an analysis by the FDA that detected NDMA impurities above an acceptable level.
Teva Pharmaceuticals USA is...
07/02/2020
Pharmacy Learning Network

Advertisement

News
Chemotherapy Injection Recalled
06/26/2020
A Class II recall is ongoing for a prescription chemotherapy medication used to treat patients with cancer of the colon or rectum.
A Class II recall is ongoing for a prescription chemotherapy medication used to treat patients with cancer of the colon or rectum.
A Class II recall is ongoing for...
06/26/2020
Pharmacy Learning Network
News
Antipsychotic Recalled
06/26/2020
The FDA is recalling a prescription antipsychotic medication used to treat patients with schizophrenia, bipolar disorders, and depression.
The FDA is recalling a prescription antipsychotic medication used to treat patients with schizophrenia, bipolar disorders, and depression.
The FDA is recalling a...
06/26/2020
Pharmacy Learning Network
News
Three Firms Recall Diabetes Drug
06/26/2020
Apotex Inc, AvKARE Inc, and PD-Rx Pharmaceuticals Inc are recalling metformin hydrochloride extended-release tablets after a FDA analysis identified a NDMA impurity in the product that was above an acceptable level.
Apotex Inc, AvKARE Inc, and PD-Rx Pharmaceuticals Inc are recalling metformin hydrochloride extended-release tablets after a FDA analysis identified a NDMA impurity in the product that was above an acceptable level.
Apotex Inc, AvKARE Inc, and...
06/26/2020
Pharmacy Learning Network

Advertisement

News
FDA Approves Selinexor for Relapsed/Refractory DLBCL
06/22/2020
The FDA granted accelerated approval to selinexor for the treatment of adult patients with DLBCL who received ≥2 prior lines of systemic therapy.
The FDA granted accelerated approval to selinexor for the treatment of adult patients with DLBCL who received ≥2 prior lines of systemic therapy.
The FDA granted accelerated...
06/22/2020
Oncology
News
Antibiotic Injection Recalled
06/19/2020
A nationwide recall is active for a prescription antibiotic used to treat bacterial infections.
A nationwide recall is active for a prescription antibiotic used to treat bacterial infections.
A nationwide recall is active...
06/19/2020
Pharmacy Learning Network
News
Blood Pressure Drug Recalled
06/19/2020
A Class III recall is active for a a prescription drug used to treat hypertension.
A Class III recall is active for a a prescription drug used to treat hypertension.
A Class III recall is active for...
06/19/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use